Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Ecnoglutide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
    Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide

    07 Jun 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/head-to-head-study-validates-the-clinical-advantage-of-new-generation-biased-glp-1-ecnoglutide-delivers-35-greater-weight-loss-than-semaglutide-302793395.html

    PR NEWSWIRE
    07 Jun 2026
    Share Share
    China Signs Off On Pfizer, Sciwind's GLP-1 Weight Loss Drug
    China Signs Off On Pfizer, Sciwind's GLP-1 Weight Loss Drug

    06 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/pfizer-breaks-obesity-market-china-approval-sciwind-partnered-glp-1

    FIERCE PHARMA
    06 Mar 2026
    Share Share
    NMPA Approves Sciwind's Ecnoglutide for Weight Management
    NMPA Approves Sciwind's Ecnoglutide for Weight Management

    06 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-ecnoglutide-injection-approved-by-chinas-national-medical-products-administration-nmpa-for-chronic-weight-management-302706442.html

    PR NEWSWIRE
    06 Mar 2026
    Share Share
    Sciwind to Highlight Positive Results for Ecnoglutide and Amylin Analogs
    Sciwind to Highlight Positive Results for Ecnoglutide and Amylin Analogs

    21 Jun 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-to-highlight-positive-results-for-injectable-ecnoglutide-phase-3-oral-ecnoglutide-phase-1-and-novel-amylin-analogs-at-the-american-diabetes-association-ada-84th-annual-conference-302178846.html

    PR NEWSWIRE
    21 Jun 2024
    Share Share
    Sciwind Announces Publication of Phase 1 Clinical Trial Results of Ecnoglutide
    Sciwind Announces Publication of Phase 1 Clinical Trial Results of Ecnoglutide

    11 Jul 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-announces-publication-of-discovery-preclinical-and-phase-1-clinical-trial-results-of-ecnoglutide-xw003-in-molecular-metabolism-301873994.html

    PR NEWSWIRE
    11 Jul 2023
    Share Share
    Sciwind to Highlight Positive Data for GLP-1 Peptide Agonist Ecnoglutide
    Sciwind to Highlight Positive Data for GLP-1 Peptide Agonist Ecnoglutide

    23 Jun 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-to-highlight-positive-clinical-data-for-glp-1-peptide-agonist-ecnoglutide-xw003-at-the-american-diabetes-association-ada-83rd-annual-conference-301858192.html

    PR NEWSWIRE
    23 Jun 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.